Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES

NIAID VACCINE ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE-MEDIATED DISEASES

Issued by NATIONAL INSTITUTES OF HEALTH · NATIONAL INSTITUTES OF HEALTH NIAID

Sol. BAA-DAIT-75N93022R00009Award NoticeBETHESDA, MD

Closed

STATUS

Closed

—

POSTED

Sep 13, 2023

Publication date

NAICS CODE

541715

Primary industry classification

PSC CODE

—

Product & service classification

AI Summary

The National Institutes of Health is announcing an award notice for the Vaccine Adjuvant Development Program focused on infectious and immune-mediated diseases. This opportunity is primarily for services related to vaccine development and biomedical research, and it is categorized as a Source Sought notice.

Contract details

Solicitation No.: BAA-DAIT-75N93022R00009
Notice Type: Award Notice
Posted Date: September 13, 2023
Response Deadline: —
NAICS Code: 541715 AI guide
Issuing Office: NATIONAL INSTITUTES OF HEALTH NIAID
Sub-Agency: NATIONAL INSTITUTES OF HEALTH
Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES
City: BETHESDA
State: MD
ZIP Code: 20892
AI Product/Service: service

Award information

Awardee: INIMMUNE CORP
Award Date: —

Description

Award notice posting

Key dates

September 13, 2023Posted Date

AI search tags

vaccine development health services biomedical research adjuvant research

Frequently asked questions

NIAID VACCINE ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE-MEDIATED DISEASES is a federal contract award from DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the award details including the awardee, contract value, and NAICS code.

SamSearch Platform

Stop searching. Start winning.

AI-powered intelligence for the right opportunities, the right leads, and the right time.

Book a Demo